1. Home
  2. CYTK vs HMY Comparison

CYTK vs HMY Comparison

Compare CYTK & HMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$75.87

Market Cap

10.7B

Sector

Health Care

ML Signal

N/A

Logo Harmony Gold Mining Company Limited

HMY

Harmony Gold Mining Company Limited

N/A

Current Price

$20.02

Market Cap

10.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
HMY
Founded
1997
1950
Country
United States
South Africa
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
10.3B
IPO Year
2004
2002

Fundamental Metrics

Financial Performance
Metric
CYTK
HMY
Price
$75.87
$20.02
Analyst Decision
Strong Buy
Buy
Analyst Count
19
2
Target Price
$89.26
$16.00
AVG Volume (30 Days)
1.8M
2.4M
Earning Date
05-05-2026
02-04-2016
Dividend Yield
N/A
2.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,368,000.00
N/A
Revenue This Year
$7.37
$37.43
Revenue Next Year
$310.19
$27.44
P/E Ratio
N/A
$15.60
Revenue Growth
N/A
N/A
52 Week Low
$35.22
$13.03
52 Week High
$88.31
$26.04

Technical Indicators

Market Signals
Indicator
CYTK
HMY
Relative Strength Index (RSI) 41.75 70.16
Support Level $73.95 $19.19
Resistance Level $80.65 $21.62
Average True Range (ATR) 2.94 0.55
MACD -0.58 0.30
Stochastic Oscillator 26.45 98.70

Price Performance

Historical Comparison
CYTK
HMY

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About HMY Harmony Gold Mining Company Limited

Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.

Share on Social Networks: